Transgenic Animals are organisms whose genetic material has been intentionally modified by introducing foreign genes from another species. This process involves the incorporation of exogenous DNA into the animal's germ line, enabling the transmission of the inserted genes to future generations. The creation of transgenic animals is a powerful tool in biomedical research, allowing scientists to study gene function, disease mechanisms, and potential therapeutic interventions. Transgenic animals are commonly generated using techniques such as microinjection, where foreign DNA is directly injected into fertilized eggs, or gene editing technologies like CRISPR-Cas9. These animals often express the introduced gene(s) in a controlled and specific manner, providing valuable insights into gene regulation and function. In biomedical research, transgenic animals are widely used to model human diseases. By introducing disease-related genes or mutations, researchers can study the development and progression of diseases, as well as test potential treatments. Additionally, transgenic animals are employed to produce valuable proteins, such as human therapeutic proteins, through the introduction of genes encoding these proteins into the animal's genome. While transgenic animals have significantly contributed to scientific advancements, ethical considerations surround their use, particularly regarding animal welfare and potential unintended consequences of genetic modifications. Strict regulations and ethical guidelines govern the creation and use of transgenic animals to ensure responsible and humane practices in research.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States